The novel c-Met inhibitor capmatinib mitigates diethylnitrosamine acute liver injury in mice
- 1 November 2016
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 261, 13-25
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer modelBMC Cancer, 2015
- The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer ModelsCancers, 2014
- Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-NonenalOxidative Medicine and Cellular Longevity, 2014
- Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research, 2013
- CD98 at the crossroads of adaptive immunity and cancerJournal of Cell Science, 2012
- Oxidation of N-Nitrosoalkylamines by Human Cytochrome P450 2A6Journal of Biological Chemistry, 2010
- Met provides essential signals for liver regenerationProceedings of the National Academy of Sciences, 2004
- Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adductsCarcinogenesis, 1996
- A rapid biuret assay for protein of whole fatty tissuesAnalytical Biochemistry, 1983
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976